Peak Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company reported revenue was $220,932. Net loss was $590,070 against $336,736 a year ago.

For the six months, the company reported revenue was $382,292. Net loss was $1,405,296 against $862,374 a year ago.